Furthermore, our results indicate that ER-status might interact with THRα-2, with a positive association between overall and breast cancer specific survival and THRα-2 status among women with ER-positive tumors and an inverse association among women with ER-negative tumors. The gene discussed is THRA; the disease is breast carcinoma.